Mumtaz Amal, Adigun Aisha O, El-Mallakh Rif S
Mood Disorders Research Program, Department of Psychiatry and Behavioral Sciences, Depression Center, University of Louisville School of Medicine, Louisville, Kentucky.
Telemed Rep. 2023 Mar 22;4(1):44-47. doi: 10.1089/tmr.2023.0004. eCollection 2023.
During the coronavirus pandemic there was a rapid adoption of telehealth services in psychiatry, which now accounts for 40% of all visits. There is a dearth of information about the relative efficacy of virtual and in-person psychiatric evaluations.
We examined the rate of medication changes during virtual and in-person visits as a proxy for the equivalence of clinical decision-making.
A total of 280 visits among 173 patients were evaluated. The majority of these visits were telehealth (224, 80%). There were 96 medication changes among the telehealth visits (42.8%) and 21 among the in-person visits (37.5%) ( = -1.4, = 0.16).
Clinicians were equally as likely to order a medication change if they saw their patient virtually or in person. This suggests that remote assessments yielded similar conclusions to in-person assessments.
在新冠疫情期间，精神病学领域迅速采用了远程医疗服务，目前其占所有就诊的40%。关于虚拟和面对面精神科评估的相对疗效，缺乏相关信息。
我们将虚拟就诊和面对面就诊期间的药物调整率作为临床决策等效性的替代指标进行了研究。
共评估了173例患者的280次就诊。其中大多数就诊为远程医疗（224次，80%）。远程医疗就诊中有96次药物调整（42.8%），面对面就诊中有21次药物调整（37.5%）（z = -1.4，p = 0.16）。
临床医生无论是通过虚拟方式还是面对面方式看诊，开出药物调整医嘱的可能性是一样的。这表明远程评估与面对面评估得出的结论相似。
